Table 1.
Study design and characteristics of included studies.
| Study | Sample | Inclusion criteria | Primary outcomes | Secondary outcome | Length of stay | Revascularization & antiplatelets |
Follow up | Risk ratio for early vs late discharge |
||
|---|---|---|---|---|---|---|---|---|---|---|
| Mortality | Readmissions | MACE | ||||||||
| Observational studies | ||||||||||
| Swaminathan 2015 | 33,920 Short LOS (n = 9135) Medium LOS (n = 15,704) Long LOS (n = 9081) |
≥65 age PPCI for STEMI 2004–2009 NCDR Database | 30-day mortality or MACE defined as composite of mortality, MI readmissions, unplanned revascularizations | 30-day all-cause mortality, readmissions for MI, unplanned revascularization, bleeding events | Very short 1–2 days Short≤3 days Medium = 4–5 days Long ≥5 days |
Femoral access 97.9% ED, 98% LD |
ED ≤ 3 days Events = 82 Total = 9135 Risk Ratio ED = 82/9135 LD > 3 days Events = 475 Total = 24,785 Risk Ratio LD = 475/24785 |
ED ≤ 3 days Events = 91 Total = 9135 Risk Ratio for ED: 91/9135 LD > 3 days Events = 318 Total = 24,785 Risk Ratio LD: 318/24785 |
ED ≤ 3 days Events = 174 Total = 9135 Risk Ratio ED: 174/9135 LD > 3 days Events = 799 > Total = 24,785 Risk Ratio LD: 799/24785 |
|
| Karabulut 2011 | 267 D/C in 1-day (90) D/C in 2 days (94) D/C in 3-days (46) D/C in >3 days (37) |
PPCI for STEMI | 1-year mortality or reinfarction or revascularization of infarct related artery. | Defining an optimal LOS according to demographic and clinical characteristics | 1-day 2-days 3-days >3-days |
Tirofiban 45.2% ED, 73% LD | 1-year |
ED ≤ 3 days Events = 1 Total = 230 Risk Ratio ED = 1/230 LD > 3 days Events = 3 Total = 37 Risk Ratio LD = 3/37 |
ED ≤ 3 days Events = 37 Total = 230 Risk Ratio ED = 37/230 LD > 3 days Events = 11 Totals = 37 Risk Ratio LD = 11/37 |
|
| Jones 2012 | 2779 D/C in 2- days (1117) D/C in 3-days (620) D/C in >3-days (916) |
PPCI for STEMI | 30-day readmissions | MACE defined as composite of death, recurrent MI, revascularization, stroke, target vessel revascularization | 2-days 3-days >3-days |
Radial access 42.5% ED, 31.2% LD GP IIb/IIIa 90% ED, 87.6% LD |
2.8 years (IQR 1.3–4.4) (median) |
ED ≤ 3 days Events = 87 Total = 1737 Risk Ratio ED: 87/1737 LD > 3 days Events = 42 Total = 916 Risk Ratio LD: 42/916 |
ED ≤ 3 days Events = 160 Total = 1737 Risk Ratio ED: 160/1737 LD > 3 days Events = 284 Total = 916 Risk Ratio LD: 284/916 |
|
| Noman 2013 | 2448 ED (1542) LD (906) |
PPCI for STEMI | Mortality at 1, 7 and 30 days | Radial access 72.6% ED, 64.1% LD Aspiration thrombectomy 45.7% ED, 39.3% LD GP IIb/IIIa inhibitors 83.3% ED, 79.4% LD DES 59.5% ED, 53.6% LD |
ED 584 days and 582 days in LD (mean) |
ED Events = 11 Total = 1542 Risk Ratio ED: 11/1542 LD Events = 15 Total = 906 Risk Ratio LD: 15/906 |
||||
| Randomized controlled clinical trials | ||||||||||
| Satilmisoglu 2016 (EDAP-PCI) | 769 ED (370) LD (363) |
PPCI for STEMI within 12 h of onset, Uneventful 24 h f/u, Single epicardial vessel to be treated | 30-day mortality | Readmission at 30 days due to reinfarction, unstable angina, arrhythmia, CHF, revascularization, stroke, major bleeding. Functional status Health related QOL | ED < 48 to 56 h. | Aspirin Clopidogrel |
30-days |
ED < 48 h to 56 h. Events = 2 Total = 370 Risk Ratio ED =2/370 LD > 48 h to 56 h. Events = 3 Total = 363 Risk Ratio LD = 3/363 |
ED < 48 h to 56 h. Events = 14 Total = 370 Risk Ratio ED = 14/370 LD > 48 h to 56 h. Events = 25 Total = 363 Risk Ratio LD = 25/363 |
|
| Melberg 2015 | 215 ED (107) LD (108) |
STEMI within 2 days of admission with Zwolle risk score ≤ 3 | 30-day mortality | 30-day readmissions Health related QOL | ED ≤3-days | DES 60% ED, 62% LD GP IIb/IIIa inhibitors 61.7% ED, 71.3% LD Aspiration thrombectomy 48.6% ED, 55.6% LD Radial access 50.5% ED, 66.7% LD |
30-days |
ED ≤ 3 days Events = 0 Total = 107 Risk Ratio ED = 0/107 LD > 3 days Events = 0 Total = 108 Risk Ratio LD = 0/108 |
ED ≤ 3 days Events = 4 Total = 107 Risk Ratio ED = 4/107 LD > 3 days Events = 3, Total = 108 Risk Ratio LD = 3/108 |
ED ≤ 3 days Events = 1 Total = 107 Risk Ratio for ED = 1/107 LD > 3 days Events = 3 Total = 108 Risk Ratio for ED = 3/108 |
| Azzalini 2015 (EDAMI) | 100 ED (54) CDS (46) |
PPC1 for STEMI within 12 h of onset, Zwolle risk score ≤ 3,symptoms | Feasibility of ED vs LD Strategy | ED ≤3-days | BMS 42% DES 56% POBA 2% Aspirin 99% Clopidogrel 88% Prasugrel 11% Ticagrelor 1% |
ED ≤ 3 days Events = 0 Total = 54 LD > 3 days Events = 0 Total = 46 |
||||
| Kotowycz 2010 (SAFE-DEPART) | 54 ED (27) LD (27) |
PPCI or Rescue PCI for STEMI | Feasibility of ED vs LD Strategy | ED ≤ 2–3 days | Aspirin Clopidogrel |
ED ≤ 3 days Events = 2 Total = 27 Risk Ratio ED = 2/27 LD > 3 days Event = 1 Total = 27 Risk Ratio LD = 1/27 |
||||
| Jirmar 2008 (PRAGUE-5) | 56 ED (37) LD (19) |
PPC1 for Uncomplicated STEMI TIMI-3 flow with <20% residual stenosis Single vessel disease EF >40% Age < 75 |
Feasibility and Safety of ED vs LD Strategy | 30-day Death Reinfarction Stroke Unstable Angina Rehospitalization Repeat target vessel revascularization Local groin complications EF |
ED ≤1 day | Aspirin Clopidogrel |
30-days |
ED ≤ 1 day Events = 1 Total = 37 Risk Ratio ED = 1/37 LD > 1 day Events = 0 Total = 19 Risk Ratio LD = 0/19 |
||
| Grines 1998 (PAMI-II) | 471 ED (237) LD (234) |
PPCI for Low-risk STEMI Age ≤70 years LVEF >45% ≤ 2-Vessel disease Successful PPCI |
Composite of death, reinfarction, unstable ischemia, stroke or CHF by 6-months | Death, reinfarction, unstable ischemia, stroke or CHF by 6-months | ED ≤3 days | Successful PTCA 96.1% TIMI Grade 3 flow 92.9% vessels |
6-months |
ED ≤ 3 days Events = 2 Total = 237 Risk Ratio ED = 2/237 LD > 3 days Events = 1 Total = 234 Risk Ratio LD = 1/234 |
ED ≤ 3 days Events = 10, Total = 237 Risk Ratio ED = 10/237 LD > 3 days Events = 9, Total = 234 Risk Ratio LD = 9/234 |
ED ≤ 3 days Events = 36 Total = 237 Risk Ratio ED = 36/237 LD > 3 days Events = 41 Total = 234 Risk Ratio LD = 41/234 |
| Novobilsky 2018 | 151 ED (76) LD (75) |
PPCI STEMI ≤ 12 h after onset Age ≤ 75 years EF >45% ≤ 2-Vessel disease Successful PPCI No arrhythmias or hemodynamic instability >2 h after PPCI |
Composite of death, MI, UA, stroke, unplanned rehospitalization, repeat target vessel revascularization, stent thrombosis at 90-days post discharge. | ED ≤3 days | DES 84.2% ED, 93.3% LD GP IIb/IIIa inhibitors 14.5% ED, 16% LD Aspiration thrombectomy 46.1% ED, 46.7% LD Radial access 98.7% ED, 100% LD |
ED ≤ 3 days Events = 0 Total = 76 Risk Ratio ED = 0/76 LD > 3 days Events = 0 Total = 75 Risk Ratio LD = 0/75 |
LD > 3 days Events = 5 Total = 76 Risk Ratio ED = 5/76 LD > 3 days Events = 6 Total = 75 Risk Ratio LD = 6/75 |
|||
APN: Advanced practice nurse, BMS: Bare Metal Stent, CDS: Conventional discharge strategy, CHF: Congestive heart failure, D/C: Discharge, DES: Drug Eluting Stent, ED: Early discharge, EF: Ejection fraction, F/u: Follow up, GP: Glycoprotein, IQR: Interquartile range, LD: Late discharge, LOS: Length of stay, MACE: Major adverse cardiovascular events, MI: Myocardial infarction, NCDR: National cardiovascular disease registry, PPCI: Primary percutaneous coronary intervention, POBA: Percutaneous Old Balloon Angioplasty, QOL: Quality of life, STEMI: ST-Elevation myocardial infarction.